Primary mediastinal large B-cell lymphoma (PMBCL) is an aggressive B-cell lymphoma
arising from thymic B-cells having clinicopathologic features distinct from systemic diffuse …

Importance To our knowledge, this is the first clinical trial designed to investigate concurrent
treatment with a checkpoint inhibitor and conventional chemotherapy in relapsed or …

Hodgkin lymphoma treatment continues to evolve as new means of assessing response to
treatment, new appreciation of important risk factors, and more effective therapeutic agents …

In this study, our aim was to compare the efficacy and toxicity profiles of gemcitabine,
cisplatin, and dexamethasone (GDP) and ifosfamide, carboplatin, and etoposide (ICE) …

Background: Non-Hodgkin's lymphomas are the eighth-most prevalent malignancy in
females and the eleventh in males. No research has been conducted comparing …

Chłoniak Hodgkina (HL) należy do rzadkich nowotworów układu chłonnego pochodzenia B-
komórkowego. Cechą charakterystyczną HL jest obecność niewielkiej liczby komórek …

Background: Enzymes, proteins, receptors, ion channels and DNA/RNA are among drug
targets. DNA-interactive drugs involve alkylation (temozolomide, chlorambucil and …

Несмотря на успехи химиотерапии первой линии классической лимфомы Ходжкина, у
части пациентов развивается рецидив или рефрактерное течение заболевания …

Hodgkin lymphoma (HL) is a rare B-cell derived lymphoid malignancy. Its typical feature is
the presence of small number of tumor cells surrounded by immune cell infiltrate of …

Висновки. Доведено, що лікарські призначення та структура споживання хворими на
лімфогранулематоз препаратів відображають характер проведеної терапії, а саме …